Nautilus Biotechnology (NAUT) Earnings Date, Estimates & Call Transcripts → AI “wealth window” is closing June 25th (From Paradigm Press) (Ad) Free NAUT Stock Alerts $2.76 -0.06 (-2.13%) (As of 05/7/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Earnings SummaryUpcoming Earnings DateAug. 7EstimatedActual EPS (Feb. 28) -$0.14 Beat By $0.02 Consensus EPS (Feb. 28) -$0.16 Read Call TranscriptListen to CallLatest SEC 10-Q Filing Get Nautilus Biotechnology Earnings AlertsEnter your email address below to receive the latest news and earnings results for NAUT and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueNAUT Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.NAUT Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaIncredible Opportunity to Retire FAST!A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Nautilus Biotechnology Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($0.68) EPSNext Year EPS Consensus Estimate: ($0.80) EPSNAUT Earnings Date and InformationNautilus Biotechnology last released its earnings results on February 28th, 2024. The reported ($0.14) earnings per share for the quarter, topping analysts' consensus estimates of ($0.16) by $0.02. Nautilus Biotechnology has generated ($0.55) earnings per share over the last year (($0.55) diluted earnings per share). Earnings for Nautilus Biotechnology are expected to decrease in the coming year, from ($0.68) to ($0.80) per share. Nautilus Biotechnology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off prior year's report dates.Read More Nautilus Biotechnology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/7/2024Estimated)------- 2/28/2024Q4 2023($0.16)($0.14)+$0.02($0.14)-- 10/31/2023Q3 2023($0.18)($0.13)+$0.05($0.13)--8/2/2023Q2 2023($0.17)($0.13)+$0.04($0.13)--5/2/2023Q1 2023($0.16)($0.12)+$0.04($0.12)--2/23/2023Q4 2022($0.15)($0.11)+$0.04($0.11)-- 11/1/2022Q3 2022($0.14)($0.11)+$0.03($0.11)-- Get the Latest News and Ratings for NAUT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nautilus Biotechnology and its competitors with MarketBeat's FREE daily newsletter. 8/2/2022Q2 2022($0.17)($0.12)+$0.05($0.12)--5/3/2022Q1 2022($0.15)($0.13)+$0.02($0.13)-- 2/24/2022Q4 2021($0.15)($0.13)+$0.02($0.13)--11/1/2021Q3 2021($0.10)($0.12)($0.02)($0.12)-- 8/9/2021Q2 2021($0.07)($0.19)($0.12)($0.19)-- Nautilus Biotechnology Earnings - Frequently Asked Questions When is Nautilus Biotechnology's earnings date? Nautilus Biotechnology has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 7th, 2024 based off last year's report dates. Learn more on NAUT's earnings history. Did Nautilus Biotechnology beat their earnings estimates last quarter? In the previous quarter, Nautilus Biotechnology (NASDAQ:NAUT) reported ($0.14) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.16) by $0.02. Learn more on analysts' earnings estimate vs. NAUT's actual earnings. How can I listen to Nautilus Biotechnology's earnings conference call? The conference call for Nautilus Biotechnology's latest earnings report can be listened to online. Listen to Conference Call How can I read Nautilus Biotechnology's conference call transcript? The conference call transcript for Nautilus Biotechnology's latest earnings report can be read online. Read Transcript How can I view Nautilus Biotechnology's earnings report? Nautilus Biotechnology's earnings report can be found in their filing with the SEC. View SEC filing How much profit does Nautilus Biotechnology generate each year? Nautilus Biotechnology (NASDAQ:NAUT) has a recorded net income of -$63.67 million. NAUT has generated -$0.55 earnings per share over the last four quarters. What is Nautilus Biotechnology's EPS forecast for next year? Nautilus Biotechnology's earnings are expected to decrease from ($0.68) per share to ($0.80) per share in the next year. More Earnings Resources from MarketBeat Related Companies: Tenaya Therapeutics Earnings Pacific Biosciences of California Earnings Akoya Biosciences Earnings Seer Earnings BioAtla Earnings Affimed Earnings ORIC Pharmaceuticals Earnings Quanterix Earnings VBI Vaccines Earnings Talaris Therapeutics Earnings Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:NAUT) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersShocking: One AI startup's revenue could surge 4,735%Manward PressBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldThe Gold Grab of the CenturyColonial MetalsThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsAI “wealth window” is closing June 25thParadigm PressStock-Picking AI Predicts #1 Stock of 2024AltimetryGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nautilus Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
